Research has demonstrated that ZNF683+CD8+T cell totality is important for anti-tumor immunity, with high levels of this ZNF683 gene marker detected in peripheral blood samples from patients with renal cell carcinoma, melanoma, and lung cancer (32). This evidence concerns the gene CD8A and lung carcinoma.